<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20</volume><submitter>Thome CH</submitter><funding>FAPESP</funding><funding>CNPq</funding><pubmed_abstract>Non-T cell activation linker (NTAL) membrane protein depletion from lipid rafts by alkylphospholipids or downregulation by shRNA knockdown decreases cell viability through regulation of the Akt/PI3K pathway in mantle cell lymphoma and acute promyelocytic leukemia cells. Here, we confirmed that the knockdown of NTAL in acute myeloid leukemia (AML) cell lines was associated with decreased cell proliferation and survival. Similarly, a xenograft model using AML cells transduced with NTAL-shRNA and transplanted into immunodeficient mice led to a 1.8-fold decrease in tumor burden. Using immunoprecipitation, LC-MS/MS analysis, and label-free protein quantification, we identified interactors of NTAL in two AML cell lines. By evaluating the gene expression signatures of the NTAL protein interactors</pubmed_abstract><journal>Molecular &amp; cellular proteomics : MCP</journal><pagination>100091</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8220000</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Expression of NTAL and Its Protein Interactors Is Associated With Clinical Outcomes in Acute Myeloid Leukemia.</pubmed_title><pmcid>PMC8220000</pmcid><pubmed_authors>Pereira-Martins DA</pubmed_authors><pubmed_authors>Thome CH</pubmed_authors><pubmed_authors>Almeida-Silveira DR</pubmed_authors><pubmed_authors>Weinhauser I</pubmed_authors><pubmed_authors>Antonio de Souza G</pubmed_authors><pubmed_authors>Houtsma R</pubmed_authors><pubmed_authors>Faca VM</pubmed_authors><pubmed_authors>Schuringa JJ</pubmed_authors><pubmed_authors>Rego EM</pubmed_authors><pubmed_authors>Augusto Dos Santos G</pubmed_authors><pubmed_authors>Ferreira GA</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Expression of NTAL and Its Protein Interactors Is Associated With Clinical Outcomes in Acute Myeloid Leukemia.</name><description>Non-T cell activation linker (NTAL) membrane protein depletion from lipid rafts by alkylphospholipids or downregulation by shRNA knockdown decreases cell viability through regulation of the Akt/PI3K pathway in mantle cell lymphoma and acute promyelocytic leukemia cells. Here, we confirmed that the knockdown of NTAL in acute myeloid leukemia (AML) cell lines was associated with decreased cell proliferation and survival. Similarly, a xenograft model using AML cells transduced with NTAL-shRNA and transplanted into immunodeficient mice led to a 1.8-fold decrease in tumor burden. Using immunoprecipitation, LC-MS/MS analysis, and label-free protein quantification, we identified interactors of NTAL in two AML cell lines. By evaluating the gene expression signatures of the NTAL protein interactors</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T17:48:09.477Z</modification><creation>2022-02-10T17:16:10.588Z</creation></dates><accession>S-EPMC8220000</accession><cross_references><pubmed>33971369</pubmed><doi>10.1016/j.mcpro.2021.100091</doi></cross_references></HashMap>